The interactive effects of ketamine and magnesium upon depressive-like pathology

Approximately one-third of patients with major depressive disorders (MDDs) are resistant to current treatment methods, and the majority of cases relapse at some point during therapy. This has resulted in novel treatments being adopted, including subanesthetic doses of ketamine, which affects aberran...

Descripción completa

Detalles Bibliográficos
Autores principales: Razmjou, Sara, Litteljohn, Darcy, Rudyk, Chris, Syed, Shuaib, Clarke, Melanie, Pentz, Rowan, Dwyer, Zach, Hayley, Shawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019465/
https://www.ncbi.nlm.nih.gov/pubmed/27660449
http://dx.doi.org/10.2147/NDT.S111131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019465/
https://www.ncbi.nlm.nih.gov/pubmed/27660449
http://dx.doi.org/10.2147/NDT.S111131

Ejemplares similares